METROPOLITAN LIFE INSURANCE CO/NY - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 65 filers reported holding ARCUS BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$59,145
+4.7%
3,295
+18.5%
0.00%0.0%
Q2 2023$56,482
+11.3%
2,7810.0%0.00%0.0%
Q1 2023$50,725
-21.9%
2,781
-11.4%
0.00%0.0%
Q4 2022$64,915
-17.2%
3,139
+4.8%
0.00%
-25.0%
Q3 2022$78,375
+3.2%
2,9960.0%0.00%
+33.3%
Q2 2022$75,919
-19.7%
2,9960.0%0.00%0.0%
Q1 2022$94,554
-80.7%
2,996
-75.3%
0.00%
-57.1%
Q4 2021$490,618
+16.1%
12,1230.0%0.01%
+16.7%
Q3 2021$422,729
+27.0%
12,1230.0%0.01%
+20.0%
Q2 2021$332,898
+5.1%
12,123
+7.5%
0.01%0.0%
Q1 2021$316,658
+3.3%
11,277
-4.5%
0.01%0.0%
Q4 2020$306,510
+51.5%
11,8070.0%0.01%
+25.0%
Q3 2020$202,372
-28.5%
11,807
+3.2%
0.00%
-20.0%
Q2 2020$283,174
+82.6%
11,446
+2.5%
0.01%
+66.7%
Q1 2020$155,040
+54.8%
11,170
+12.7%
0.00%
+50.0%
Q4 2019$100,142
-4.7%
9,915
-14.1%
0.00%0.0%
Q3 2019$105,069
+14.5%
11,5460.0%0.00%0.0%
Q2 2019$91,791
-27.4%
11,546
+14.0%
0.00%0.0%
Q1 2019$126,461
+2.5%
10,125
-11.6%
0.00%0.0%
Q4 2018$123,41311,4590.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$29,404,28419.15%
Decheng Capital Management III (Cayman), LLC 869,790$15,864,9706.40%
Octagon Capital Advisors LP 2,172,000$39,617,2805.70%
Boxer Capital, LLC 1,432,200$26,1231.28%
PFM Health Sciences, LP 1,559,947$28,453,4331.26%
SECTORAL ASSET MANAGEMENT INC 293,646$5,356,1031.03%
DAFNA Capital Management LLC 175,217$3,195,9580.96%
Ikarian Capital, LLC 230,000$4,195,2000.95%
Tejara Capital Ltd 50,000$912,0000.47%
Capital Impact Advisors, LLC 20,501$373,9380.46%
View complete list of ARCUS BIOSCIENCES INC shareholders